- All sections
- C - Chemistry; metallurgy
- C08L - Compositions of macromolecular compounds
- C08L 5/04 - Alginic acid; Derivatives thereof
Patent holdings for IPC class C08L 5/04
Total number of patents in this class: 442
10-year publication summary
27
|
24
|
41
|
46
|
35
|
52
|
42
|
43
|
58
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Board of Regents, The University of Texas System | 5604 |
12 |
Case Western Reserve University | 1769 |
10 |
President and Fellows of Harvard College | 5904 |
7 |
Northwestern University | 3271 |
6 |
Mochida Pharmaceutical Co., Ltd. | 345 |
5 |
Nisshinbo Holdings Inc. | 350 |
5 |
Sigilon Therapeutics, Inc. | 89 |
5 |
The General Hospital Corporation | 4637 |
4 |
Allergan Pharmaceuticals International Limited | 242 |
4 |
Cresilon, Inc. | 22 |
4 |
Drexel University | 969 |
4 |
Norwegian University of Science and Technology (ntnu) | 175 |
4 |
Nordovo Biosciences AS | 5 |
4 |
Alginor ASA | 16 |
4 |
The Regents of the University of California | 19479 |
3 |
Massachusetts Institute of Technology | 9903 |
3 |
Academisch Ziekenhuis Maastricht | 179 |
3 |
Decision Sciences Medical Company, LLC | 34 |
3 |
Kemira Oyj | 1203 |
3 |
Novamont S.p.A. | 357 |
3 |
Other owners | 346 |